NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

Some of those 170 patients (maybe 90ish) likely included the Expanded Access Protocol (EAP) trial patients... those who did not enter the main arm of the trial but had vaccine made for them. These would have been whose patients who had rapid or psPD from chemo/rad, not enough vaccine material to make 5+ doses, and other reasons. It would have probably also included the info arm patients (50ish?).

These patients date back to October 2019, and so would not include any new compassionate use or specials patients since then.